Kristen Pierce - 07 Jan 2026 Form 4 Insider Report for CERO THERAPEUTICS HOLDINGS, INC. (CERO)

Role
Chief Development Officer
Signature
/s/ Andrew Kucharchuk, Attorney-in-Fact
Issuer symbol
CERO
Transactions as of
07 Jan 2026
Net transactions value
$0
Form type
4
Filing time
09 Jan 2026, 16:30:21 UTC
Previous filing
02 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pierce Kristen Chief Development Officer CERO THERAPEUTICS HOLDINGS, INC., 201 HASKINS WAY, SUITE 230, SOUTH SAN FRANCISCO /s/ Andrew Kucharchuk, Attorney-in-Fact 09 Jan 2026 0002039649

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CERO Stock Option (Right to Buy) Award $0 +1,612,099 $0.000000 1,612,099 07 Jan 2026 Common Stock 1,612,099 $0.0550 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.